Anaesthetic complications associated with myotonia congenita: Case study and comparison with other myotonic disorders

Acta Anaesthesiologica Scandinavica

Volumn 47, Issue 5, 2003, Pages 630-634

  Farbu, E ^a   Softeland E ^a   Bindoff, L A ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anaesthetic complications; Malignant hyperthermia; Myotonia congenita

Indexed keywords

CHLORIDE CHANNEL; FENTANYL; PROPOFOL; SUXAMETHONIUM; THIOPENTAL;

ADULT; ANESTHESIA COMPLICATION; ARTICLE; BREATHING DISORDER; CASE REPORT; ELECTROMYOGRAPHY; FEMALE; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; MALIGNANT HYPERTHERMIA; MUSCLE SPASM; MYOTONIA; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; THOMSEN DISEASE;

ADULT; ANESTHESIA; ELECTROMYOGRAPHY; FEMALE; HUMANS; ION CHANNELS; MYOTONIA CONGENITA; MYOTONIC DISORDERS; NEUROMUSCULAR DEPOLARIZING AGENTS; SPASM; SUCCINYLCHOLINE;

EID: 0037623285     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2003.00116.x     Document Type: Article

References (20)

1. Jurkat-Rott K, Lehmann-Horn F. Human muscle voltage-gated ion channels and hereditary disease. Curr Opin Pharmacol 2001; 1: 280-7.
2. Koch MC, Steinmeyer K, Lorenz C et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992; 257: 797-800.
3. Sun C, Tranebjaerg L, Torbergsen T, Holmgren G, van Ghelue M. Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia. Eur J Hum Genet 2001; 9: 903-9.
4. Russell SH, Hirsch NP. Anaesthesia and myotonia. Br J Anaesth 1994; 72: 210-6.
5. Cooper EC, Jan LY. Ion channel genes and human neurological disease, recent progress, prospects, and challenges. Proc Natl Acad Sci USA 1999; 96: 4759-66.
6. Baur CP, Schara U, Schlecht R, Georgieff M, Lehmann-Horn F. [Anaesthesia in neuromuscular disorders. Part 2: specific disorders]. Anasthesiol Intensivmed Notfallmed Schmerzther 2002; 37: 125-37.
7. Savarese JJ, Caldwell JE, Lien CA, Miller RD. Pharmacology of Muscle Relaxants and Their Antagonists. In: Miller RD, ed. Anaesthesia. Philadelphia: Churchill Livingstone, 2000: 412-26.
8. Morgan GE, Mikhail MS. Clinical Anaesthesiology, 2nd edn. Stamford, CT: Prentice Hall International, Inc. Appleton and Lange, 1996.
9. Meola G. Clinical and genetic heterogeneity in myotonic dystrophies. Muscle Nerve 2000; 23: 1789-99.
10. Finsterer J. Myotonic dystrophy type 2. Eur J Neurol 2002; 9: 441-7.
11. Colovic V, Walker RW. Myotonia dystrophlca and spinal surgery. Paediatr Anaesth 2002; 12: 351-5.
12. White RJ, Bass S. Anaesthetic management of a patient with myotonic dystrophy. Paediatr Anaesth 2001; 11: 494-7.
13. Jurkat-Rott K, McCarthy T, Lehmann-Horn F. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 2000; 23: 4-17.
14. Manning BM, Quane KA, Ording H et al. Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation. Am J Hum Genet 1998; 62: 599-609.
15. Quane KA, Healy JM, Keating KE et al. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet 1993; 5: 51-5.
16. Ording H, Brancadoro V, Cozzolino S et al. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand 1997; 41: 955-66.
17. Robinson RL, Brooks C, Brown SL et al. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes. Hum Mutat 2002; 20: 88-97.
18. Heier T, Guttormsen AB. Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: a report including 3 cases. Acta Anaesthesiol Scand 2000; 44: 775-81.
19. The International Collaborative Study of Severe Anaphylaxis. An epidemiologic study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks. Epidemiology 1998; 9: 141-6.
20. Moss J. Muscle relaxants and histamine release. Acta Anaesthesiol Scand Suppl 1995; 106: 7-12.